Pacific Edge shares more than doubled in value on confirmation of acceptance under a key US medical regulation for its Cxbladder cancer test. The shares jumped as high as 68 cents from 27 cents yesterday, and were recently at 55 cents, up 104 percent and valuing the company at...
Richard Yan’s lawyer says there’s no point bankrupting his client and he can’t pay security for the upcoming Mainzeal appeal.
The economic fallout from the coronavirus pandemic is making preparing company accounts and the audit process trickier, requiring more disclosure and taking longer, according to KPMG partner John Kensington. "There's a lot of crystal ball-gazing to be done," Kensington told th...
Fulton Hogan warns there’s significant uncertainty about the outlook for major infrastructure on both sides of the Tasman, with commercial contracts deferred and little visibility on public work. The privately-owned civil construction firm told shareholders last week that its...